Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Current Deferred Revenue (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Current Deferred Revenue for 3 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Deferred Revenue rose 82.21% year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Sep 2025, up 82.21%, and an annual FY2024 reading of $11.7 million, up 465.91% over the prior year.
  • Current Deferred Revenue was $1.0 million for Q3 2025 at SBC Medical Group Holdings, up from $512123.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $11.7 million in Q4 2024 and bottomed at $512123.0 in Q2 2025.
  • Average Current Deferred Revenue over 3 years is $2.7 million, with a median of $797955.5 recorded in 2024.
  • The sharpest move saw Current Deferred Revenue skyrocketed 465.91% in 2024, then skyrocketed 82.21% in 2025.
  • Year by year, Current Deferred Revenue stood at $2.1 million in 2023, then surged by 465.91% to $11.7 million in 2024, then tumbled by 91.22% to $1.0 million in 2025.
  • Business Quant data shows Current Deferred Revenue for SBC at $1.0 million in Q3 2025, $512123.0 in Q2 2025, and $525497.0 in Q1 2025.